Evidence map›Paper›PMID 40008001›Full record

ArticleFrontiers in oncology2025

A novel truncated fusion gene

Jiao Lu, Guanqun Yang, Qiurong Zhang, Man Wang, Lijun Wang, Lu Chen, Haoyue Chen, Xin Jiang, Chunhua Liu, Tong Lin and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jiao Lu *Department of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Guanqun Yang *Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Suzhou, Jiangsu, China.
Qiurong Zhang *Department of Hematology, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, Jiangsu, China.
Man WangNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Lijun WangNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Lu ChenDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Haoyue ChenDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Xin JiangDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Chunhua LiuDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Tong LinDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Qiaoyan HanDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.
Zefa LiuDepartment of Hematology, People's Hospital of Xinghua City, Taizhou, Jiangsu, China.
Shi ZhenNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Zhao ZengNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Jinlan PanNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Jiannong CenNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Suning ChenNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Zheng WangNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
Xingxia ZhangDepartment of Hematology, Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, Jiangsu, China.
Miao SunDepartment of Hematology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gene ETV6 has been confirmed to be a genetic susceptibility gene for thrombocytopenia and leukemia. Here, we report a long-chain noncoding RNA AC010198.2 as a novel fusion partner of ETV6, showing a karyotype of del(12)(p13p11), with poor prognosis in a post-MPN AML that has never been reported, which may be an vital initial event in the transformation of MPN to AML and deterioration of disease.

Indexed as

AC010198.2AMLETV6MPNnovel

Identifiers

PMID40008001
PMCPMC11850314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.